Treatment | Without trastuzumab | With trastuzumab | p-value | |
---|---|---|---|---|
Group 1 n(%) | Group 2 n(%) | Group 3 n(%) | ||
Chemotherapy regimen | ||||
EC-T | 203 (79.6) | 248 (84.4) | 238 (81.0) | 0.846 |
TCb | 37 (14.5) | 35 (11.9) | 39 (13.3) | |
P | 8 (3.1) | 6 (2.0) | 10 (3.4) | |
Others | 7 (2.7) | 5 (1.7) | 7 (2.9) | |
Radiotherapy | ||||
No | 114 (44.7) | 124 (42.2) | 141 (48.0) | 0.369 |
Yes | 141 (55.3) | 170 (57.8) | 153 (52.0) | |
Endotherapy | ||||
No | 142 (55.7) | 162 (55.1) | 160 (54.4) | 0.956 |
Yes | 113 (44.3) | 132 (44.9) | 134 (45.6) | |
Total | 255 (100.0) | 294 (100.0) | 294 (100.0) |